Christoph U. Correll

机构：Northwell Health, Feinstein Institute for Medical Research, Hofstra University, Humboldt-Universität zu Berlin, German Center for Pediatric and Adolescent Rheumatology, Einstein Center Digital Future, Orygen Youth Health, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, German Centre for Cardiovascular Research, North Shore Diabetes and Endocrine Associates, Einstein Center for Neurosciences Berlin, Zucker Hillside Hospital, Charité - Universitätsmedizin Berlin · ORCID：0000-0002-7254-5646

发表论文 1974 篇 · 总被引 87580 次 · h-index 150

代表论文

• Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis (2025 · European Neuropsychopharmacology · 被引 16)
• Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders (2025 · JAMA Psychiatry · 被引 15)
• Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and personality disorders: nationwide and meta-analytic comparisons with other antipsychotics (2025 · The Lancet Psychiatry · 被引 10)
• Joint detection of risk for psychotic disorders or bipolar disorders in clinical practice in the UK: development and validation of a clinical prediction model (2025 · The Lancet Psychiatry · 被引 5)
• Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies (2025 · EBioMedicine · 被引 5)
• Benefits and risks of antipsychotic discontinuation in people with first and multi-episode psychotic disorders or with schizophrenia: why, when, how and in whom? (2025 · Schizophrenia · 被引 2)